欢迎访问东方智库
会员登录 | 免费注册
讲师入驻通道
免费咨询热线：13810808675
MariondeJong MariondeJong,Ph.D.,isaProfessorofNuclearBiologyattheDepartmentsofNuclearMedicineandRadiologyatErasmusMCinRotterdam/TheNetherlands.ShegotherPhDdegreein1993attheErasmusMC.SheisthechairoftheSPECTRIMgroupinmolecularimagingandtherapy,shewaspromotedasprofessorin2006.MariondeJonghas(co)publishedmorethan300peer-reviewedpapersininternationaljournals(H-Indexis54),holdsseveralpatents,obtainedmanygrantsandshe,aswellasherteammembers,receivednumerousawards.Shewaspromotor(supervisor)of>30pastandcurrentPhDstudents.SheischairoftheTranslationalMolecularImagingCommitteeoftheEuropeanAssociationofNuclearMedicine(EANM),memberoftheMolecularImagingCommitteefortheEuropeanSocietyofRadiology,VicechairoftheNantesCyclotron(Arronax)ScientificCommittee,MemberofthenationalVIDIcommitteeandChairoftheExpertCommitteeoftheAnimalImagingFacilityatErasmusMC.Hermajorscientificinterestsinclude:1)Translationalimagingandradionuclidetherapyoftumoursandotherlesionsusingtheranosticradiopharmaceuticals,withafocusonradiolabelledpepti
Sofie Pattijn Plus20yearsofexperienceinthefieldofvaccineanddrugdevelopment.Invivo/Exvivo/InVitroscreeningandevaluationofunwantedandwantedimmunogenicityusingdifferentcellularassaysandtechniques(predictive/preclinicalimmunogenicityassessmentusingprimaryanimalandhumancellsandinvivoanimalmodels).Optimizationandsuccessfulimplementationofdifferentimmuneresponseassays/techniques(ELISPOT,flowcytometry,tetramer,cytotoxassays..).Clinicalcorrelatefinding/researchindifferentclinicaltrials(HCV,HBV,HPV,RA).Rationalvaccinedesignbycombininginsilicoandinvitrotools.Designandsupportofdevelopmentofnewmethods/assaystoevaluateimmuneresponsesandtechnology/knowledgetransfer.Peoplemanagementandtraining,teamplayer,gettingthebestoutofeachmemberSpecialties:projectmanagement,processoptimization,dynamicchangesandchallenges,bringingideastothemarket.Motivatingothersandcreatingdynamicteams.Broadnetworkinimmunogenicitycommunity,activeparticipationatseveralconferencesandworkinggroups/communities.Uptodatewithregularguidelinesandstrong
热点文章
-
02-18 / (4271)
-
02-29 / (2717)
联系我们
微信咨询
微信扫一扫
